Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants
Public ClinicalTrials.gov record NCT04382586. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study of Zanubrutinib Treatment in Patients Hospitalized for COVID-19 Infection and Pulmonary Distress
Study identification
- NCT ID
- NCT04382586
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- BeiGene
- Industry
- Enrollment
- 63 participants
Conditions and interventions
Conditions
Interventions
- Zanubrutinib Drug
- Supportive Care Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 5, 2020
- Primary completion
- Jan 31, 2021
- Completion
- Jan 31, 2021
- Last update posted
- Oct 25, 2024
2020 – 2021
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St Jude Medical Center | Fullerton | California | 92835 | — |
| Medstar Heath Research Institute Medstar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| John D Archbold Memorial Hospital | Thomasville | Georgia | 31792 | — |
| Loyola University Medical Center | Maywood | Illinois | 60153 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| The Brigham and Womens Hospital, Inc | Boston | Massachusetts | 02115 | — |
| Rutgers University Hospital | Newark | New Jersey | 07103 | — |
| Therapeutics Concepts | Houston | Texas | 77004 | — |
| Joe Arrington Cancer Research and Treatment Center | Lubbock | Texas | 79410 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04382586, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 25, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04382586 live on ClinicalTrials.gov.